181 related articles for article (PubMed ID: 7497581)
1. Pharmacological attempts to improve the bioavailability of oral etoposide.
Joel SP; Clark PI; Heap L; Webster L; Robbins S; Craft H; Slevin ML
Cancer Chemother Pharmacol; 1995; 37(1-2):125-33. PubMed ID: 7497581
[TBL] [Abstract][Full Text] [Related]
2. The effect of antacid, metoclopramide, and propantheline on the bioavailability of metoprolol and atenolol.
Regårdh CG; Lundborg P; Persson BA
Biopharm Drug Dispos; 1981; 2(1):79-87. PubMed ID: 7236872
[TBL] [Abstract][Full Text] [Related]
3. The influence of gastric emptying on droxicam pharmacokinetics.
Sánchez J; Martínez L; García-Barbal J; Roser R; Bartlett A; Sagarra R
J Clin Pharmacol; 1989 Aug; 29(8):739-45. PubMed ID: 2778095
[TBL] [Abstract][Full Text] [Related]
4. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
[TBL] [Abstract][Full Text] [Related]
5. Stability of the i.v. and oral formulations of etoposide in solution.
Joel SP; Clark PI; Slevin ML
Cancer Chemother Pharmacol; 1995; 37(1-2):117-24. PubMed ID: 7497580
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability of etoposide after oral administration of the solution marketed for intravenous use: therapeutic and pharmacoeconomic perspectives.
Aguilar Ponce JL; Flores-Picazo Y; Pérez-Urizar J; Castañeda-Hernández G; Zinser-Sierra JW; Dueñas-González A; Calderón-Flores E; Segura-Pacheco BA; de la Garza-Salazar J
Arch Med Res; 1999; 30(3):212-5. PubMed ID: 10427872
[TBL] [Abstract][Full Text] [Related]
7. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
Li C; Li X; Choi JS
Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics and pharmacodynamics of oral etoposide.
Toffoli G; Corona G; Sorio R; Robieux I; Basso B; Colussi AM; Boiocchi M
Br J Clin Pharmacol; 2001 Nov; 52(5):511-9. PubMed ID: 11736859
[TBL] [Abstract][Full Text] [Related]
9. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
Lee HT; Lee YJ; Chung SJ; Shim CK
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.
Zucchetti M; Pagani O; Torri V; Sessa C; D'Incalci M; De Fusco M; de Jong J; Gentili D; Martinelli G; Tinazzi A
Clin Cancer Res; 1995 Dec; 1(12):1517-24. PubMed ID: 9815952
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer.
Millward MJ; Newell DR; Yuen K; Matthews JP; Balmanno K; Charlton CJ; Gumbrell L; Lind MJ; Chapman F; Proctor M
Cancer Chemother Pharmacol; 1995; 37(1-2):161-7. PubMed ID: 7497587
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability studies with ciglitazone in beagles. II. Effect of propantheline bromide and metoclopramide HCL on bioavailability of a tablet.
Cox SR; Harrington EL; Capponi VJ
Biopharm Drug Dispos; 1985; 6(1):81-90. PubMed ID: 3986303
[TBL] [Abstract][Full Text] [Related]
13. Gastric emptying and the pharmacokinetics of the cephalosporin antibiotic, cefpodoxime proxetil.
Hughes GS; Heald DL; Patel R; Spillers CR; Batts DH; Euler AR
Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):197-204. PubMed ID: 2352449
[TBL] [Abstract][Full Text] [Related]
14. Influence of the pharmacological modification of gastric emptying on lactose digestion and gastrointestinal symptoms.
Peuhkuri K; Vapaatalo H; Nevala R; Korpela R
Aliment Pharmacol Ther; 1999 Jan; 13(1):81-6. PubMed ID: 9892883
[TBL] [Abstract][Full Text] [Related]
15. Effect of altered gastric emptying and gastrointestinal motility on metformin absorption.
Marathe PH; Wen Y; Norton J; Greene DS; Barbhaiya RH; Wilding IR
Br J Clin Pharmacol; 2000 Oct; 50(4):325-32. PubMed ID: 11012555
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic optimisation of treatment with oral etoposide.
Toffoli G; Corona G; Basso B; Boiocchi M
Clin Pharmacokinet; 2004; 43(7):441-66. PubMed ID: 15139794
[TBL] [Abstract][Full Text] [Related]
17. Influence of cisapride, metoclopramide and loperamide on gastric emptying of normal volunteers as measured by means of the area under the curve of the cumulative fraction absorbed-time profiles of paracetamol.
van Wyk M; Sommers DK; Moncrieff J
Methods Find Exp Clin Pharmacol; 1992 Jun; 14(5):379-82. PubMed ID: 1513194
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic approach to compare oral and i.v. administration of etoposide.
Würthwein G; Krümpelmann S; Tillmann B; Real E; Schulze-Westhoff P; Jürgens H; Boos J
Anticancer Drugs; 1999 Oct; 10(9):807-14. PubMed ID: 10587290
[TBL] [Abstract][Full Text] [Related]
19. Effect of grapefruit juice intake on etoposide bioavailability.
Reif S; Nicolson MC; Bisset D; Reid M; Kloft C; Jaehde U; McLeod HL
Eur J Clin Pharmacol; 2002 Oct; 58(7):491-4. PubMed ID: 12389073
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability and pharmacokinetic features of etoposide in childhood acute lymphoblastic leukemia patients.
Chen CL; Rawwas J; Sorrell A; Eddy L; Uckun FM
Leuk Lymphoma; 2001 Jul; 42(3):317-27. PubMed ID: 11699396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
